{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:07:19Z","timestamp":1790478439490,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1124\/jpet.115.225466","type":"journal-article","created":{"date-parts":[[2015,7,16]],"date-time":"2015-07-16T02:00:03Z","timestamp":1437012003000},"page":"471-482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia"],"prefix":"10.1016","volume":"354","author":[{"given":"Pascal","family":"Bonaventure","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Shelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujin","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Nepomuceno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Aluisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Lord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Shoblock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Welty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra R.","family":"Chaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuleima","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Halter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Ndifor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Koudriakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Rizzolio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Letavic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas I.","family":"Carruthers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Lovenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Dugovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.115.225466_bib1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nm1544","article-title":"Promotion of sleep by targeting the orexin system in rats, dogs and humans","volume":"13","author":"Brisbare-Roch","year":"2007","journal-title":"Nat Med"},{"key":"10.1124\/jpet.115.225466_bib2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0092-8674(00)81973-X","article-title":"Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation","volume":"98","author":"Chemelli","year":"1999","journal-title":"Cell"},{"key":"10.1124\/jpet.115.225466_bib3","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.115.225466_bib4","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.115.225466_bib5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1124\/jpet.109.152009","article-title":"Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat","volume":"330","author":"Dugovic","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.115.225466_bib6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fnins.2014.00028","article-title":"Orexin-1 receptor blockade dysregulates REM sleep in the presence of orexin-2 receptor antagonism","volume":"8","author":"Dugovic","year":"2014","journal-title":"Front Neurosci"},{"key":"10.1124\/jpet.115.225466_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fnins.2014.00008","article-title":"Effects of a newly developed potent orexin-2 receptor-selective antagonist, compound 1 m, on sleep\/wakefulness states in mice","volume":"8","author":"Etori","year":"2014","journal-title":"Front Neurosci"},{"key":"10.1124\/jpet.115.225466_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fnins.2014.00005","article-title":"LSN2424100: a novel, potent orexin-2 receptor antagonist with selectivity over orexin-1 receptors and activity in an animal model predictive of antidepressant-like efficacy","volume":"8","author":"Fitch","year":"2014","journal-title":"Front Neurosci"},{"key":"10.1124\/jpet.115.225466_bib9","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00213-010-2092-4","article-title":"JNJ-39220675, a novel selective histamine H3 receptor antagonist, reduces the abuse-related effects of alcohol in rats","volume":"214","author":"Galici","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.115.225466_bib10","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1016\/j.bmcl.2003.08.038","article-title":"N-acyl 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline: the first orexin-2 receptor selective non-peptidic antagonist","volume":"13","author":"Hirose","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/jpet.115.225466_bib11","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.npep.2013.10.009","article-title":"Orexin in sleep, addiction and more: is the perfect insomnia drug at hand?","volume":"47","author":"Hoyer","year":"2013","journal-title":"Neuropeptides"},{"key":"10.1124\/jpet.115.225466_bib12","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/sj.bjp.0705610","article-title":"Characterisation of the binding of [3H]-SB-674042, a novel nonpeptide antagonist, to the human orexin-1 receptor","volume":"141","author":"Langmead","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.115.225466_bib13","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1021\/acs.jmedchem.5b00742","article-title":"Novel octahydropyrrolo[3,4-c]pyrroles are selective orexin-2 antagonists: SAR leading to a clinical candidate","volume":"58","author":"Letavic","year":"2015","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.115.225466_bib14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)81965-0","article-title":"The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene","volume":"98","author":"Lin","year":"1999","journal-title":"Cell"},{"key":"10.1124\/jpet.115.225466_bib15","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/j.1476-5381.2009.00127.x","article-title":"Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX(2) receptor","volume":"156","author":"Malherbe","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.115.225466_bib16","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.5665\/sleep.2232","article-title":"The dual orexin receptor antagonist almorexant induces sleep and decreases orexin-induced locomotion by blocking orexin 2 receptors","volume":"35","author":"Mang","year":"2012","journal-title":"Sleep"},{"key":"10.1124\/jpet.115.225466_bib17","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1016\/j.bmcl.2004.06.032","article-title":"Novel substituted 4-phenyl-[1,3]dioxanes: potent and selective orexin receptor 2 (OX(2)R) antagonists","volume":"14","author":"McAtee","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/jpet.115.225466_bib18","doi-asserted-by":"crossref","first-page":"6620","DOI":"10.1016\/j.bmcl.2013.10.045","article-title":"Discovery of 2,5-diarylnicotinamides as selective orexin-2 receptor antagonists (2-SORAs)","volume":"23","author":"Mercer","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/jpet.115.225466_bib19","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2005"},{"key":"10.1124\/jpet.115.225466_bib20","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nat Med"},{"key":"10.1124\/jpet.115.225466_bib21","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.bmcl.2014.12.056","article-title":"Discovery of piperidine ethers as selective orexin receptor antagonists (SORAs) inspired by filorexant","volume":"25","author":"Raheem","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/jpet.115.225466_bib22","doi-asserted-by":"crossref","unstructured":"Roecker AJ, Mercer SP, Bergman JM, Gilbert KF, Kuduk SD, Harrell CM, Garson SL, Fox SV, Gotter AL, Tannenbaum PL, et al. (2015) Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacements. Bioorg Med Chem Lett DOI: 10.1016\/j.bmcl.2014.12.081 [published ahead of print].","DOI":"10.1016\/j.bmcl.2014.12.081"},{"key":"10.1124\/jpet.115.225466_bib23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/cmdc.201300447","article-title":"Discovery of 5\u2032'-chloro-N-[(5,6-dimethoxypyridin-2-yl)methyl]-2,2\u2032:5\u2032,3\u2032'-terpyridine-3\u2032-carboxamide (MK-1064): a selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia","volume":"9","author":"Roecker","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1124\/jpet.115.225466_bib24","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1016\/j.bmcl.2014.08.041","article-title":"Discovery of MK-3697: a selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia","volume":"24","author":"Roecker","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/jpet.115.225466_bib25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"key":"10.1124\/jpet.115.225466_bib26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/bph.12261","article-title":"Discovery and development of orexin receptor antagonists as therapeutics for insomnia","volume":"171","author":"Winrow","year":"2014","journal-title":"Br J Pharmacol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524191021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524191021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.115.225466","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:35:10Z","timestamp":1739993710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524191021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0022356524191021"],"URL":"https:\/\/doi.org\/10.1124\/jpet.115.225466","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.115.225466","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}